Le Lézard
Classified in: Health
Subjects: TRI, FDA

Agfa HealthCare Receives FDA 510(k) Clearance for Advanced Clinical Applications on XERO Universal Viewer


MORTSEL, Belgium and GREENVILLE, South Carolina, July 27, 2017 /PRNewswire/ --

Agfa HealthCare announces today that it has received FDA 510(k) clearance for the XERO Xtend functionalities of the Enterprise Imaging zero-footprint viewer. XERO Xtend adds 3D processing and advanced clinical applications to the XERO Viewer. It is now FDA-cleared for diagnostic viewing on desktop devices.1 The release data for 510K cleared XERO Xtend will be communicated by Agfa HealthCare's regional sales teams.

Versatile, powerful universal viewer
The XERO Viewer provides secure access to DICOM and non-DICOM imaging data from different departments and multiple sources, in one view, to anyone inside and outside of the hospital who is subject to defined security policies and access rights.

Images from the Agfa HealthCare Enterprise Imaging IT platform or third-party VNAs or PACS can be seen securely in one display. XERO Viewer connects more service lines than any other product in the market.

Powerful tools, more modalities
XERO Xtend is an optional feature set for the XERO Viewer. It includes MIP (maximum intensity projection), MPR (multiplanar reconstruction) and 3D visualization tools; orthopaedic tools (center line, Cobb Angle, Hip-Knee-Ankle Angle, etc.); mammography tools (including displays and tools for optimal viewing); and nuclear medicine tools (color highlighting palettes stored as window level presets).

Agfa HealthCare has also expanded the types of modalities that can be used for diagnostic review and reporting in XERO. Uncompressed or non-lossy compressed images intended "for presentation" may be used for diagnosis or screening when viewed on monitors that have been cleared by the FDA.

In addition, the Full Fidelity Mobile functionality (mobile diagnostic review and analysis on an iPad), which received FDA 510(k) clearance in 2015 now includes ECG images and reports.

Winning product quality, range of attributes
The XERO Viewer recently received top honors from KLAS, with its 2017 Category Leader Award. This is the first year the healthcare quality research organization has included a Universal Image Viewer category. The Category Leader designation is reserved for vendor solutions that lead select market segments in which at least two products meet a minimum level of KLAS confidence. According to the latest KLAS Performance Report, Agfa HealthCare is one of two vendors offering universal viewers that are fast and reliable, and noted for continually improving their solutions.

"We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion," comments James Jay, President, Imaging IT Solutions at Agfa HealthCare. "XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."

For an image, courtesy of Agfa HealthCare, click here

About Agfa HealthCare
Agfa HealthCare, present in one hospital out of two, is a leading provider of eHealth & Digital Imaging solutions. Care organizations in over 100 countries rely on Agfa HealthCare to optimize their efficiency and improve patient care.

1 This FDA 510k clearance for Xtend functionality does not include mobile viewing using the XERO Viewer at this time.

Miriam Ladin
Director, Marketing Communications, Americas
T +1-401-604-2203
miriam[email protected] 

 

SOURCE Agfa HealthCare


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...



News published on and distributed by: